Clinical Trial Update: Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown Lines [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating botulinum toxin type A (BOTOX) for moderate to severe glabellar lines in Chinese patients; study completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facial Lines or Wrinkles
• Glabellar Rhytides

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Glabellar Rhytides | Phase 4 | Status: COMPLETED | Results posted: 2015-09-01